Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Broaden Accessibility of Breakthrough Treatment for Heart Failure: A Prospective, Propensity-Matched CED to Access the Impact of Cardiac Contractility Modulation Therapy (CCM)

NCT07209098 is registered in ClinicalTrials.gov with Impulse Dynamics as lead sponsor.

NCT NCT07209098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07209098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Broaden Accessibility of Breakthrough Treatment for Heart Failure: A Prospective, Propensity-Matched CED to Access the Impact of Cardiac Contractility Modulation Therapy (CCM)
Lead sponsor
Impulse Dynamics
Phase
Observational
Overall status
Recruiting
Start date
November 18, 2025
Completion date
April 30, 2031
Enrollment
4,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure and reduced ejection fraction, nyha class iii heart failure